Concepts (137)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Memory | 5 | 2017 | 214 | 2.060 |
Why?
|
| Association Learning | 5 | 2019 | 36 | 1.830 |
Why?
|
| Dopamine Uptake Inhibitors | 5 | 2017 | 152 | 1.520 |
Why?
|
| Cocaine | 6 | 2017 | 555 | 1.500 |
Why?
|
| Neurons | 10 | 2020 | 881 | 1.430 |
Why?
|
| Prefrontal Cortex | 5 | 2019 | 640 | 1.400 |
Why?
|
| Reward | 7 | 2022 | 201 | 1.290 |
Why?
|
| Adrenergic beta-Antagonists | 4 | 2017 | 189 | 1.000 |
Why?
|
| Parvalbumins | 1 | 2022 | 29 | 0.840 |
Why?
|
| Hypothalamic Area, Lateral | 2 | 2019 | 17 | 0.840 |
Why?
|
| Conditioning, Operant | 2 | 2014 | 241 | 0.790 |
Why?
|
| Neural Pathways | 3 | 2019 | 324 | 0.760 |
Why?
|
| Midline Thalamic Nuclei | 1 | 2019 | 3 | 0.680 |
Why?
|
| Glucose | 1 | 2021 | 307 | 0.680 |
Why?
|
| Receptors, Adrenergic, beta | 3 | 2017 | 153 | 0.670 |
Why?
|
| Cues | 4 | 2019 | 654 | 0.650 |
Why?
|
| Appetitive Behavior | 2 | 2020 | 18 | 0.620 |
Why?
|
| Computer Simulation | 1 | 2021 | 706 | 0.590 |
Why?
|
| Analgesics, Opioid | 1 | 2022 | 498 | 0.580 |
Why?
|
| Neuronal Plasticity | 2 | 2017 | 274 | 0.580 |
Why?
|
| Models, Biological | 1 | 2021 | 981 | 0.570 |
Why?
|
| Norepinephrine | 2 | 2014 | 276 | 0.550 |
Why?
|
| Mitochondria | 1 | 2021 | 643 | 0.540 |
Why?
|
| Fear | 2 | 2014 | 239 | 0.540 |
Why?
|
| Extinction, Psychological | 3 | 2019 | 240 | 0.540 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 2 | 2017 | 266 | 0.520 |
Why?
|
| Animals | 20 | 2022 | 20881 | 0.490 |
Why?
|
| Receptor, trkB | 1 | 2014 | 27 | 0.470 |
Why?
|
| Rats, Long-Evans | 5 | 2017 | 203 | 0.470 |
Why?
|
| Conditioning, Classical | 3 | 2019 | 57 | 0.470 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2014 | 124 | 0.430 |
Why?
|
| Patch-Clamp Techniques | 5 | 2020 | 204 | 0.420 |
Why?
|
| Mice | 13 | 2022 | 8474 | 0.400 |
Why?
|
| Propranolol | 1 | 2011 | 103 | 0.370 |
Why?
|
| Neural Inhibition | 1 | 2011 | 80 | 0.370 |
Why?
|
| Calcium | 3 | 2022 | 929 | 0.370 |
Why?
|
| Memory Disorders | 1 | 2011 | 111 | 0.350 |
Why?
|
| Hippocampus | 1 | 2013 | 471 | 0.350 |
Why?
|
| Axons | 2 | 2021 | 139 | 0.340 |
Why?
|
| Signal Transduction | 2 | 2017 | 2689 | 0.330 |
Why?
|
| Behavior, Animal | 3 | 2020 | 470 | 0.290 |
Why?
|
| Social Behavior | 2 | 2020 | 164 | 0.290 |
Why?
|
| Cocaine-Related Disorders | 1 | 2011 | 504 | 0.270 |
Why?
|
| Amygdala | 2 | 2020 | 159 | 0.260 |
Why?
|
| Rats | 5 | 2015 | 5300 | 0.260 |
Why?
|
| Ventral Tegmental Area | 3 | 2019 | 74 | 0.230 |
Why?
|
| Male | 14 | 2020 | 37321 | 0.220 |
Why?
|
| Protein Precursors | 2 | 2020 | 105 | 0.220 |
Why?
|
| Receptors, Opioid | 2 | 2020 | 60 | 0.220 |
Why?
|
| Sucrose | 1 | 2022 | 58 | 0.210 |
Why?
|
| Optogenetics | 2 | 2019 | 20 | 0.210 |
Why?
|
| Calcium Signaling | 2 | 2020 | 97 | 0.200 |
Why?
|
| Cilia | 2 | 2019 | 94 | 0.200 |
Why?
|
| Paraventricular Hypothalamic Nucleus | 1 | 2020 | 15 | 0.180 |
Why?
|
| Eye Abnormalities | 1 | 2019 | 15 | 0.180 |
Why?
|
| Kidney Diseases, Cystic | 1 | 2019 | 31 | 0.170 |
Why?
|
| Memory, Long-Term | 1 | 2019 | 4 | 0.170 |
Why?
|
| Opioid Peptides | 1 | 2019 | 17 | 0.170 |
Why?
|
| Glutamic Acid | 2 | 2019 | 332 | 0.170 |
Why?
|
| Mice, Inbred C57BL | 4 | 2019 | 2791 | 0.170 |
Why?
|
| Abnormalities, Multiple | 1 | 2019 | 109 | 0.160 |
Why?
|
| Cerebellum | 1 | 2019 | 103 | 0.160 |
Why?
|
| Corpus Striatum | 2 | 2017 | 279 | 0.160 |
Why?
|
| Oxytocin | 1 | 2020 | 124 | 0.150 |
Why?
|
| Retina | 1 | 2019 | 252 | 0.150 |
Why?
|
| Transcriptome | 1 | 2019 | 164 | 0.150 |
Why?
|
| Synaptic Potentials | 1 | 2017 | 8 | 0.150 |
Why?
|
| Spatial Behavior | 1 | 2017 | 18 | 0.150 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2019 | 208 | 0.150 |
Why?
|
| Craving | 1 | 2019 | 200 | 0.150 |
Why?
|
| Preoptic Area | 1 | 2017 | 19 | 0.140 |
Why?
|
| Neurotensin | 1 | 2017 | 37 | 0.140 |
Why?
|
| Microscopy, Fluorescence, Multiphoton | 1 | 2017 | 27 | 0.140 |
Why?
|
| Interneurons | 1 | 2017 | 70 | 0.140 |
Why?
|
| Receptors, AMPA | 1 | 2017 | 99 | 0.140 |
Why?
|
| Pyramidal Cells | 1 | 2017 | 79 | 0.140 |
Why?
|
| Molecular Imaging | 1 | 2017 | 45 | 0.140 |
Why?
|
| Thalamus | 1 | 2017 | 82 | 0.140 |
Why?
|
| Locomotion | 1 | 2017 | 135 | 0.140 |
Why?
|
| Movement | 1 | 2017 | 179 | 0.130 |
Why?
|
| MAP Kinase Signaling System | 1 | 2017 | 247 | 0.130 |
Why?
|
| Disease Models, Animal | 4 | 2020 | 2550 | 0.130 |
Why?
|
| Adrenergic beta-2 Receptor Antagonists | 1 | 2015 | 4 | 0.130 |
Why?
|
| Microscopy | 1 | 2016 | 64 | 0.130 |
Why?
|
| Receptors, Adrenergic, beta-1 | 1 | 2015 | 7 | 0.130 |
Why?
|
| Adrenergic beta-1 Receptor Antagonists | 1 | 2015 | 7 | 0.130 |
Why?
|
| Adaptation, Psychological | 1 | 2019 | 447 | 0.130 |
Why?
|
| Optical Imaging | 1 | 2016 | 46 | 0.130 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 2015 | 34 | 0.130 |
Why?
|
| Motivation | 1 | 2019 | 561 | 0.130 |
Why?
|
| Mental Recall | 1 | 2015 | 72 | 0.130 |
Why?
|
| Synapses | 1 | 2017 | 222 | 0.120 |
Why?
|
| Flavanones | 1 | 2014 | 6 | 0.120 |
Why?
|
| Nerve Net | 1 | 2016 | 181 | 0.110 |
Why?
|
| Nucleus Accumbens | 1 | 2017 | 417 | 0.110 |
Why?
|
| Drug-Seeking Behavior | 1 | 2015 | 213 | 0.100 |
Why?
|
| Self Administration | 1 | 2014 | 419 | 0.100 |
Why?
|
| Obesity | 1 | 2019 | 1076 | 0.100 |
Why?
|
| Mice, Transgenic | 3 | 2019 | 1033 | 0.090 |
Why?
|
| Secondary Prevention | 1 | 2011 | 291 | 0.090 |
Why?
|
| Neurogenesis | 2 | 2019 | 32 | 0.080 |
Why?
|
| Action Potentials | 2 | 2020 | 223 | 0.080 |
Why?
|
| Nerve Tissue Proteins | 2 | 2020 | 290 | 0.070 |
Why?
|
| Brain | 1 | 2016 | 2176 | 0.060 |
Why?
|
| Arousal | 1 | 2020 | 168 | 0.040 |
Why?
|
| Receptors, Oxytocin | 1 | 2020 | 9 | 0.040 |
Why?
|
| Clozapine | 1 | 2020 | 46 | 0.040 |
Why?
|
| Genes, Reporter | 1 | 2020 | 191 | 0.040 |
Why?
|
| Wakefulness | 1 | 2020 | 75 | 0.040 |
Why?
|
| Vesicular Glutamate Transport Protein 2 | 1 | 2019 | 4 | 0.040 |
Why?
|
| Microfilament Proteins | 1 | 2020 | 102 | 0.040 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2019 | 26 | 0.040 |
Why?
|
| Drinking Behavior | 1 | 2019 | 20 | 0.040 |
Why?
|
| Exploratory Behavior | 1 | 2020 | 79 | 0.040 |
Why?
|
| Single-Cell Analysis | 1 | 2019 | 35 | 0.040 |
Why?
|
| Benzodiazepines | 1 | 2020 | 130 | 0.040 |
Why?
|
| Diet, High-Fat | 1 | 2019 | 81 | 0.040 |
Why?
|
| Autistic Disorder | 1 | 2020 | 77 | 0.040 |
Why?
|
| Pyrazoles | 1 | 2020 | 190 | 0.040 |
Why?
|
| Acoustic Stimulation | 1 | 2019 | 206 | 0.040 |
Why?
|
| ADP-Ribosylation Factors | 1 | 2017 | 4 | 0.040 |
Why?
|
| Receptors, Somatostatin | 1 | 2017 | 7 | 0.040 |
Why?
|
| Estrous Cycle | 1 | 2017 | 23 | 0.040 |
Why?
|
| Odorants | 1 | 2017 | 52 | 0.030 |
Why?
|
| Miniaturization | 1 | 2016 | 21 | 0.030 |
Why?
|
| Random Allocation | 1 | 2017 | 442 | 0.030 |
Why?
|
| Endoscopes | 1 | 2016 | 36 | 0.030 |
Why?
|
| Estradiol | 1 | 2017 | 176 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2020 | 1692 | 0.030 |
Why?
|
| Prostheses and Implants | 1 | 2016 | 159 | 0.030 |
Why?
|
| Mutation | 1 | 2019 | 1213 | 0.030 |
Why?
|
| Equipment Design | 1 | 2016 | 500 | 0.030 |
Why?
|
| Dopamine | 1 | 2017 | 474 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2017 | 2673 | 0.030 |
Why?
|
| Female | 3 | 2019 | 38074 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2015 | 1745 | 0.020 |
Why?
|
| Humans | 1 | 2014 | 68618 | 0.020 |
Why?
|